Publications

Crawford, J, Dale, DC, and Lyman, GH. "Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management." Cancer 100, no. 2 (January 2004): 228-237. (Review)

PMID
14716755
Full Text

Kimmick, G, Ratain, MJ, Berry, D, Woolf, S, Norton, L, Muss, HB, and Cancer and Leukemia Group B (CALGB 9041), . "Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041)." Invest New Drugs 22, no. 1 (January 2004): 83-89.

PMID
14707498
Scholars@Duke

Adams, JR, Elting, LS, Lyman, GH, George, JN, Lembersky, BC, Armitage, JO, Demetri, GD, and Bennett, CL. "Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries." Am J Med 116, no. 1 (January 1, 2004): 28-34.

PMID
14706663
Scholars@Duke

Yeazel, MW, Gurney, JG, Oeffinger, KC, Mitby, PA, Mertens, AC, Hudson, MM, and Robison, LL. "An examination of the dental utilization practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study." Journal of Public Health Dentistry 64, no. 1 (January 2004): 50-54.

PMID
15078062
Full Text

Stadler, WM, Atkins, MB, George, DJ, Jr, WGK, Teh, BT, and Figlin, RA. "Therapeutic options for variant renal cancer: A true orphan disease." Clinical Cancer Research 10, no. 18 II (2004): 6393s-6396s.

PMID
15448037
Full Text

Davis, DW, Shen, Y, Mullani, NA, Wen, S, Herbst, RS, O'Reilly, M, Abbruzzese, JL, and McConkey, DJ. "Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors." Clinical cancer research : an official journal of the American Association for Cancer Research 10, no. 1 Pt 1 (January 2004): 33-42.

PMID
14734449
Full Text

Crawford, J, Dale, DC, and Lyman, GH. "Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237))." Cancer 100, no. 9 (2004): 1993-1994.

Scholars@Duke

Gradishar, WJ, Meza, LA, Amin, B, Samid, D, Hill, T, Chen, Y-M, Lower, EE, Marcom, PK, and Iqbal, S. "Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study." Women's Oncology Review 4, no. 4 (2004): 283-285.

Full Text

Shear, NH, Redelmeier, DA, Callen, JP, Bickers, DR, Bigby, ME, Reed, BR, Shear, NH, Strauss, JS, Harpe, SE, Lyman, GH, Culakova, E, Griggs, J, Velicer, CM, Heckbert, SR, Potter, JD, and Taplin, SH. "Use of antibiotics and risk of cancer [1] (multiple letters)." Journal of the American Medical Association 291, no. 22 (2004): 2699-2700.

PMID
15187044
Scholars@Duke

Rich, JN, Reardon, DA, Peery, T, Dowell, JM, Quinn, JA, Penne, KL, Wikstrand, CJ, Van Duyn, LB, Dancey, JE, McLendon, RE, Kao, JC, Stenzel, TT, Ahmed Rasheed, BK, Tourt-Uhlig, SE, Herndon, JE, Vredenburgh, JJ, Sampson, JH, Friedman, AH, Bigner, DD, and Friedman, HS. "Phase II trial of gefitinib in recurrent glioblastoma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 22, no. 1 (January 2004): 133-142.

PMID
14638850
Full Text

Pages